SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 58 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 533 | -84.9% | 0.00% | – |
| Q1 2022 | $4,000 | -90.0% | 3,537 | -71.7% | 0.00% | – |
| Q4 2021 | $40,000 | +81.8% | 12,499 | +156.0% | 0.00% | – |
| Q3 2021 | $22,000 | +4.8% | 4,882 | +23.9% | 0.00% | – |
| Q2 2021 | $21,000 | +40.0% | 3,941 | +101.8% | 0.00% | – |
| Q1 2021 | $15,000 | +7.1% | 1,953 | +55.4% | 0.00% | – |
| Q4 2020 | $14,000 | -86.0% | 1,257 | -88.8% | 0.00% | – |
| Q3 2020 | $100,000 | +53.8% | 11,262 | +85.5% | 0.00% | – |
| Q2 2020 | $65,000 | +6400.0% | 6,070 | +3272.2% | 0.00% | – |
| Q1 2020 | $1,000 | -90.9% | 180 | -88.2% | 0.00% | – |
| Q4 2019 | $11,000 | – | 1,521 | +5144.8% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 29 | -94.8% | 0.00% | – |
| Q3 2018 | $6,000 | +200.0% | 563 | +270.4% | 0.00% | – |
| Q2 2018 | $2,000 | – | 152 | +406.7% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 30 | -97.2% | 0.00% | – |
| Q3 2017 | $16,000 | – | 1,068 | +4754.5% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 22 | -96.3% | 0.00% | – |
| Q1 2017 | $10,000 | +233.3% | 599 | +152.7% | 0.00% | – |
| Q4 2016 | $3,000 | +200.0% | 237 | +137.0% | 0.00% | – |
| Q3 2016 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
| IFP Advisors, Inc | 50 | $1,000 | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |